Rulonilimab

Tax included
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity.
MedChemExpress 
HY-P99895

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
Application
COVID-19-immunoregulation
CAS
2417124-95-7